EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Sphingosine‐1‐Phosphate Signaling Attenuates Doxorubicin‐Aggravated Bone Loss in Obese Breast Cancer Mice

Yu Zhang iD, Hao Shen, Junjie Niu iD, Yingkang Huang, Can Zhu, Yi Wang, Yida Chen, Xinyi Cheng, Huilin Yang iD, Xianrong Zhang, Hao Chen, Hongbo Zhang iD und 1 weitere

Smart Medicine · 2026-04 · 5 (2)

DOI: 10.1002/smmd.70031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Smart Medicine, online erschienen am 30.03.2026. Verfasst von Yu Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics The First Affiliated Hospital of Soochow University Orthopedic Institute of Soochow University Suzhou Jiangsu China. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although chemotherapy‐induced bone loss is well‐recognized during breast cancer treatment, the underlying mechanism remains to be further elucidated, especially in patients with obesity. In this study, the objective was to investigate the impact of genomic silencing and pharmacological inhibition of S1P synthesis on bone loss in doxorubicin‐induced obese breast cancer mice. In vitro study, upon the treatment of doxorubicin combined with palmitic acid, the S1P generated by 4T1 cells was significantly increased, resulting in an increase in osteoclastogenesis by activating the S1PR1/p‐STAT3/NFATc‐1 pathway in bone marrow‐derived macrophages. In vivo study, pharmacological intervention with Sphingosine kinases (SPHK) antagonist SKI II or biological inhibition with SPHK1 and SPHK2 short hairpin RNA significantly reduced S1P production and rescued the obese breast cancer‐bearing mice from doxorubicin‐induced bone loss, manifested by the decreased osteoclastogenesis and recovered bone microarchitecture. Similarly, the administration of the S1PR1 antagonist FTY720 also alleviated bone loss in the breast cancer‐bearing mice fed a high‐fat diet. These studies indicate that genetic silencing and pharmacological inhibition can suppress S1P‐dependent bone loss in doxorubicin‐induced obese breast cancer mice. S1P shows promise as a potential drug target for preventing chemotherapy‐induced bone loss in patients.

Schlagwörter

Stichwörter der Autor:innen

bone lossbreast cancerdoxorubicinobesitysphingosine‐1‐phosphate

Autor:innen und Institutionen

  • Department of Orthopedics The First Affiliated Hospital of Soochow University Orthopedic Institute of Soochow University Suzhou Jiangsu China.
  • Pharmaceutical Sciences Laboratory Faculty of Science and Engineering Åbo Akademi University Turku Finland.
  • Department of Orthopedics Nanfang Hospital Southern Medical University Guangzhou Guangdong China.
  • Medical College Yangzhou University Yangzhou Jiangsu China.
  • Turku Bioscience Centre University of Turku and Åbo Akademi University Turku Finland.

ORCID-Profile: Yu Zhang, Junjie Niu, Huilin Yang, Hongbo Zhang, Qin Shi

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Shen, H., Niu, J., Huang, Y., Zhu, C., Wang, Y., Chen, Y., Cheng, X., Yang, H., Zhang, X., Chen, H., Zhang, H., & Shi, Q. (2026). Targeting Sphingosine‐1‐Phosphate Signaling Attenuates Doxorubicin‐Aggravated Bone Loss in Obese Breast Cancer Mice. Smart Medicine, 5(2). https://doi.org/10.1002/smmd.70031

Vancouver

Zhang Y, Shen H, Niu J, Huang Y, Zhu C, Wang Y, et al. Targeting Sphingosine‐1‐Phosphate Signaling Attenuates Doxorubicin‐Aggravated Bone Loss in Obese Breast Cancer Mice. Smart Medicine. 2026;5(2). doi:10.1002/smmd.70031

BibTeX
@article{Zhang2026,
  author = {Zhang, Yu and Shen, Hao and Niu, Junjie and Huang, Yingkang and Zhu, Can and Wang, Yi and Chen, Yida and Cheng, Xinyi and Yang, Huilin and Zhang, Xianrong and Chen, Hao and Zhang, Hongbo and Shi, Qin},
  title = {Targeting Sphingosine‐1‐Phosphate Signaling Attenuates Doxorubicin‐Aggravated Bone Loss in Obese Breast Cancer Mice},
  journal = {Smart Medicine},
  year = {2026},
  volume = {5},
  number = {2},
  doi = {10.1002/smmd.70031}
}
Kostenlos starten →